ORIC Pharmaceuticals, Inc.
ORIC
$5.26
-$0.52-9.00%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 6.80% | 0.55% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.27% | 6.39% | |||
| Operating Income | -3.27% | -6.39% | |||
| Income Before Tax | -5.04% | -8.14% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -5.04% | -8.14% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -5.04% | -8.14% | |||
| EBIT | -3.27% | -6.39% | |||
| EBITDA | -3.20% | -6.44% | |||
| EPS Basic | -4.88% | -7.83% | |||
| Normalized Basic EPS | -4.86% | -7.85% | |||
| EPS Diluted | -4.88% | -7.83% | |||
| Normalized Diluted EPS | -4.86% | -7.85% | |||
| Average Basic Shares Outstanding | 0.15% | 0.28% | |||
| Average Diluted Shares Outstanding | 0.15% | 0.28% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
